Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Yangxun Wu"'
Publikováno v:
BMC Geriatrics, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Older patients with coronary artery disease (CAD) are particularly vulnerable to the efficacy and adverse drug reactions, and may therefore particularly benefit from personalized medication. Drug–gene interactions (DGIs) occur w
Externí odkaz:
https://doaj.org/article/350f442ffea540c9b87d2747fe66a9e2
Publikováno v:
Thrombosis Journal, Vol 22, Iss 1, Pp 1-8 (2024)
Abstract Background Platelet is enriched with Circular RNAs (circRNAs), with circFAM13B rank among the 10 most abundant circRNAs in platelets. The aim of the present study was to evaluate the predictive value of platelet-derived circFAM13B for the an
Externí odkaz:
https://doaj.org/article/c4aa0c48c3534bc59c17985c20ab7ef2
Autor:
Xu Zhang, Yangxun Wu, Chao Lv, Shizhao Zhang, Haiping Liu, Yuyan Wang, Yuting Zou, Liu’an Qin, Junmeng Zhang, Tong Yin
Publikováno v:
Thrombosis Journal, Vol 20, Iss 1, Pp 1-11 (2022)
Abstract Background This study aimed to evaluate the efficacy and safety of oral anticoagulants (OACs) in real-world elderly patients with comorbidities of stable coronary artery disease (SCAD) and atrial fibrillation (AF). Methods Elderly patients (
Externí odkaz:
https://doaj.org/article/f73b3d3a138c4963b181ad5dc155b025
Publikováno v:
Thrombosis Journal, Vol 20, Iss 1, Pp 1-11 (2022)
Abstract Background Despite strong antiplatelet therapy with ticagrelor, serious ischemic events still occur in patients with acute coronary syndrome (ACS). The predictability of platelet reactivity to the residual risk of ischemic events during tica
Externí odkaz:
https://doaj.org/article/20fde24b51d94cac9a5bb290f36db2bb
Autor:
Yangxun Wu, Haiping Liu, Liu'an Qin, Yuyan Wang, Shizhao Zhang, Ziqian Wang, Yuting Zou, Tong Yin
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundThe efficacy and safety of antithrombotic treatment with oral anticoagulants (OACs) in elderly patients with comorbidities of acute coronary syndrome (ACS) and atrial fibrillation (AF) are unclear.MethodsA cohort of hospitalized elderly pat
Externí odkaz:
https://doaj.org/article/d5a93fb327d14f488572e2be2a931aa7
Autor:
Yangxun Wu, Guanyun Wang, Lisha Dong, Liu'an Qin, Jian Li, Hengming Yan, Wenjie Guo, Xiaodong Feng, Yuting Zou, Ziqian Wang, Rina Du, Yuxiao Zhang, Jing Ma, Tong Yin
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Purpose: Coronary artery disease (CAD) and atrial fibrillation (AF) often coexist and lead to a much higher risk of mortality in the elderly population. The aim of this study was to investigate whether the CHA2DS2-VASc score could predict the risk of
Externí odkaz:
https://doaj.org/article/e237fab274ad419e8fe1e0c58b6546db
Autor:
Jia Liu, Guanyun Wang, Liu’an Qin, Yangxun Wu, Yuting Zou, Xuyun Wang, Ziqian Wang, Yuyan Wang, Shizhao Zhang, Yuxiao Zhang, Tong Yin
Publikováno v:
Cardiology Research and Practice, Vol 2021 (2021)
Background. This study aimed to analyse the role of the HAS-BLED score with the addition of genotype bins for bleeding risk prediction in warfarin-treated patients with atrial fibrillation (AF). Methods and Results. Consecutive patients with AF on in
Externí odkaz:
https://doaj.org/article/7c9d4bd528fc434cb25065fd0c6633ab
Background Despite strong antiplatelet therapy with ticagrelor, serious ischemic events still occur in patients with acute coronary syndrome (ACS). The predictability of platelet reactivity to the residual risk of ischemic events during ticagrelor tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0047db5eeccda000948ccd623086e25a
https://doi.org/10.21203/rs.3.rs-1431361/v1
https://doi.org/10.21203/rs.3.rs-1431361/v1
Autor:
Jun Liu, Liuan Qin, Yangxun Wu, Jia Liu, Li Peng, Yuting Zou, Tong Yin, Rina Du, Ziqian Wang, Xuyun Wang
Publikováno v:
Thrombosis Research. 186:71-74
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acb17d4d361b002168b4c74d1d121e16
https://doi.org/10.1016/j.thromres.2019.12.016
https://doi.org/10.1016/j.thromres.2019.12.016
Autor:
Ying Jin, Jing Ma, Ziqian Wang, Yuting Zou, Guanyun Wang, Yangxun Wu, Yuyan Wang, Haiping Liu, Tong Yin, Ping Ye
Publikováno v:
Journal of cardiovascular translational research. 15(6)
The ABCD-GENE score was constructed to identify patients with high platelet reactivity (HPR) after 30 days of clopidogrel treatment. In our study, 1297 eligible patients with acute coronary syndrome (ACS) were included, and 44 (3.4%) major adverse ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6934b88b9ad09d035be207bc2a1b9d85
https://pubmed.ncbi.nlm.nih.gov/35437618
https://pubmed.ncbi.nlm.nih.gov/35437618